ICHR financial statements and SEC filings
ICHR annual income statement
| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
|---|
| 2025-12-26 | $947.65M | -$39.27M | -$52.78M | 10-K |
| 2024-12-27 | $849.04M | -$7.64M | -$20.82M | 10-K |
| 2023-12-29 | $811.12M | -$10.89M | -$42.98M | 10-K |
| 2022-12-30 | $1.28B | $85.82M | $72.80M | 10-K |
| 2021-12-31 | $1.10B | $81.01M | $70.90M | 10-K |
| 2020-12-25 | $914.24M | $41.55M | $33.28M | 10-K |
ICHR annual balance sheet
| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
|---|
| 2025-12-26 | $942.88M | $278.99M | $663.89M | 10-Q |
| 2024-12-27 | $995.56M | $297.23M | $698.34M | 10-K |
| 2023-12-29 | $938.48M | $373.80M | $564.68M | 10-K |
| 2022-12-30 | $1.08B | $496.25M | $587.50M | 10-K |
| 2021-12-31 | $1.02B | $520.16M | $500.71M | 10-K |
| 2020-12-25 | $774.17M | $362.48M | $411.69M | 10-K |
ICHR annual cash flow
| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
|---|
| 2025-12-26 | $29.89M | -$36.17M | -$4.10M | 10-K |
| 2024-12-27 | $27.88M | -$17.64M | $18.47M | 10-K |
| 2023-12-29 | $57.63M | -$15.50M | -$48.65M | 10-K |
| 2022-12-30 | $31.45M | -$29.43M | $8.46M | 10-K |
| 2021-12-31 | $15.27M | -$20.84M | $96.91M | 10-K |
| 2020-12-25 | $38.26M | -$10.30M | $168.62M | 10-K |